- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||urelumab|
|Search PubMed titles||urelumab|
|Search PubMed titles/abstracts||urelumab|
|Urelumab (BMS-663513) is an investigational monoclonal antibody with agonist activity at the tumour necrosis factor (TNF) receptor, 4-1BB (TNFRSF9), being investigated for potential clinical immunostimulatory activity in the immuno-oncology setting [2-4].
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Peptide sequences for urelumab are identical matches for peptides claimed in patent WO2005035584, which leads to identification of clone 20H4-9-IgG4 .